Domainex logo — Enrich your medicines pipeline

Domainex

Enrich your medicines pipeline

Founded 2002 United Kingdom Saffron Walden, United Kingdom 100 employees Grant Total: $3.74M Biotechnology, Creator Economy

General Information

Company Name Domainex
Founded Year 2002
Location United Kingdom Saffron Walden, United Kingdom +1
Employees 100
Industries Biotechnology, Creator Economy
Funding Stage Grant
Social

Get notified when Domainex moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Domainex

Domainex is a biotechnology company founded in 2001 and based near Cambridge, United Kingdom. The company specializes in providing fully integrated drug discovery services to the pharmaceutical, biotechnology, academic, and patient foundations globally. Domainex has a strong success record, delivering an average of one candidate drug every year for the past six years. The company's services include medicinal chemistry, fragment screening, computational chemistry, assay development and screening, iPSC and immune cell biology, protein production, CDH technology, analytical chemistry, and X-ray crystallography services, making it a one-stop solution for drug discovery programs. Domainex's last investment of £118.00K was a grant investment received on 23 January 2018 from Innovate UK. The company's focus on providing efficient and well-considered scientific solutions has resulted in a 30% time-saving compared to industry standards, making it an attractive option for prudent management of budgets within drug discovery projects.

Taxonomy: Drug Discovery, Medicinal Chemistry, Computational Chemistry, Assay Development, Protein Production, Analytical Chemistry, X-ray Crystallography, Fragment Screening, Virtual Screening, Molecular Biology, Cell Biology, Oncology, Kinase Inhibitor Research, Protease Inhibitor Research, Biochemistry

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
23 Jan 2018
Grant •••••• - 09 Jul 2014
Series A •••••• 3
Investor Investor Investor
01 Feb 2013
Venture Round •••••• 3
Investor Investor
•••• ••••
17 Feb 2010
Venture Round •••••• 2
Investor Investor
23 Apr 2008

Domainex Alternatives & Competitors

Domainex vs

The Integrated Fragment Discovery Engine

44 employees
Biotechnology, Health Care
Domainex vs

Preferred Research Partner for Preclinical Discovery

24 employees
Biotechnology, Life Sciences
Domainex vs

We aspire to be a world class innovative drug discovery company from China.

Unknown
40 employees
Biotechnology, Pharmaceutical

FAQ About Domainex

Enrich your medicines pipeline
Domainex was founded in 2002.
Domainex is headquartered in Saffron Walden, United Kingdom.
Domainex operates in the following industries: Biotechnology, Creator Economy.
Domainex has approximately 100 employees.
Domainex has completed 5 funding rounds, raising a total of $3.74M. The latest funding stage is Grant.
Top alternatives and competitors to Domainex include ZoBio, TheraIndx Lifesciences Pvt.Ltd., Regor Therapeutics Group, SARomics Biostructures AB, Genosco. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Domainex and ZoBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Domainex and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy